Multi-Site Validation Study Published Supporting Astute Medical's NephroCheck ... - Proteo Monitor

Multi-Site Validation Study Published Supporting Astute Medical's NephroCheck ...
Proteo Monitor
Barasch said that in several large studies done by himself, Devarajan, and Max Delbruck researcher Kai Schidt-Ott, NGAL predicted AKI with an AUC in the .80 range, roughly equivalent to the performance of the NephroCheck test. Barasch also noted that ...